Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Viatris IncVTRS · Entity 3277 | See Remarks | June 25, 2026 | June 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Viatris Inc
Report date June 25, 2026 · Filed June 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 316,212 |
Reported balance
After 2026-06-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-25 · Sale · Disposed 50,076 · Balance 316,212 F1: These shares of common stock were sold pursuant to a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, that was adopted by the reporting person on March 24, 2026. F2: Represents the weighted average price of the reporting person's disposition of 50,076 shares of common stock in transactions ranging from $15.979 to $16.31. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 318 |
Reported balance
Holding disclosure · report date 2026-06-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 318 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of common stock were sold pursuant to a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, that was adopted by the reporting person on March 24, 2026.
F2: Represents the weighted average price of the reporting person's disposition of 50,076 shares of common stock in transactions ranging from $15.979 to $16.31. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Mylan II B.V.
Report date November 16, 2020 · Filed November 19, 2020
Section 16 reporting ended · disclosed 2020-11-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectBy Spouse | 933 |
Reported balance
After 2020-11-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-11-16 · Grant · Acquired 933 · Balance 933 F25: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectBy Spouse | 0 |
Reported balance
After 2020-11-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-11-16 · Disposition to issuer · Disposed 933 · Balance 0 F16: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F25: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. |
Filing footnotes · ownership attribution and instrument terms
F16: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination.
F25: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 20,595 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 26 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,595 Underlying: Common Stock · 20,595 shares Expires not disclosed F13 · security: One-third of these options vested on each of March 2, 2019 and March 2, 2020 and one-third will vest on March 2, 2021. F14 · price: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F24 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest in three equal annual installments beginning on March 2, 2021. F24 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 669 | Not disclosed Strike: $17.48 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 25 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 669 Underlying: Common Stock · 669 shares Expires 2030-03-02 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F23 · derivative.exercise_date: These options will vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 11,071 | Not disclosed Strike: $17.48 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 24 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,071 Underlying: Common Stock · 11,071 shares Expires 2030-03-02 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F22 · derivative.exercise_date: 3,691 of these options will vest on March 2, 2021 and 3,690 will vest on each of March 2, 2022 and March 2, 2023. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 577 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 23 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 577 Underlying: Common Stock · 577 shares Expires not disclosed F15 · security: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F16 · price: Received in exchange for, and having substantially the same terms as (other than no longer being subject to the performance-based vesting conditions), performance restricted stock units of Mylan in connection with the Combination. F21 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2022. F21 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 15,483 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 22 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,483 Underlying: Common Stock · 15,483 shares Expires not disclosed F15 · security: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F16 · price: Received in exchange for, and having substantially the same terms as (other than no longer being subject to the performance-based vesting conditions), performance restricted stock units of Mylan in connection with the Combination. F21 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2022. F21 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 770 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 21 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 770 Underlying: Common Stock · 770 shares Expires not disclosed F13 · security: One-third of these options vested on each of March 2, 2019 and March 2, 2020 and one-third will vest on March 2, 2021. F14 · price: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F20 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 385 of the RSUs will vest on each of March 2, 2021 and March 2, 2022. F20 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 385 of the RSUs will vest on each of March 2, 2021 and March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 8,258 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 20 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,258 Underlying: Common Stock · 8,258 shares Expires not disclosed F13 · security: One-third of these options vested on each of March 2, 2019 and March 2, 2020 and one-third will vest on March 2, 2021. F14 · price: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F19 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 4,129 of the RSUs will vest on each of March 2, 2021 and March 2, 2022. F19 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 4,129 of the RSUs will vest on each of March 2, 2021 and March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 460 | Not disclosed Strike: $27.45 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 19 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 460 Underlying: Common Stock · 460 shares Expires 2029-03-01 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F18 · derivative.exercise_date: 154 of these options vested on March 2, 2020 and 153 will vest on each of March 2, 2021 and March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 7,398 | Not disclosed Strike: $27.45 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 18 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,398 Underlying: Common Stock · 7,398 shares Expires 2029-03-01 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F17 · derivative.exercise_date: One-third of these options vested on March 2, 2020 and one-third will vest on each of March 2, 2021 and March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 501 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 17 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 501 Underlying: Common Stock · 501 shares Expires not disclosed F15 · security: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F16 · price: Received in exchange for, and having substantially the same terms as (other than no longer being subject to the performance-based vesting conditions), performance restricted stock units of Mylan in connection with the Combination. F15 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F15 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 9,900 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 16 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 Underlying: Common Stock · 9,900 shares Expires not disclosed F15 · security: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F16 · price: Received in exchange for, and having substantially the same terms as (other than no longer being subject to the performance-based vesting conditions), performance restricted stock units of Mylan in connection with the Combination. F15 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F15 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 167 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 15 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 167 Underlying: Common Stock · 167 shares Expires not disclosed F13 · security: One-third of these options vested on each of March 2, 2019 and March 2, 2020 and one-third will vest on March 2, 2021. F14 · price: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F15 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F15 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 1,980 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 14 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,980 Underlying: Common Stock · 1,980 shares Expires not disclosed F13 · security: One-third of these options vested on each of March 2, 2019 and March 2, 2020 and one-third will vest on March 2, 2021. F14 · price: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F15 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F15 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 612 | Not disclosed Strike: $40.97 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 13 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 612 Underlying: Common Stock · 612 shares Expires 2028-03-02 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F13 · derivative.exercise_date: One-third of these options vested on each of March 2, 2019 and March 2, 2020 and one-third will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 9,681 | Not disclosed Strike: $40.97 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 12 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,681 Underlying: Common Stock · 9,681 shares Expires 2028-03-02 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F13 · derivative.exercise_date: One-third of these options vested on each of March 2, 2019 and March 2, 2020 and one-third will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 4,392 | Not disclosed Strike: $45.18 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 11 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,392 Underlying: Common Stock · 4,392 shares Expires 2027-03-03 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F12 · derivative.exercise_date: These options vested on March 3, 2020. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 4,181 | Not disclosed Strike: $46.27 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 10 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,181 Underlying: Common Stock · 4,181 shares Expires 2026-02-17 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F11 · derivative.exercise_date: These options vested on February 17, 2019. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 2,059 | Not disclosed Strike: $55.61 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 9 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,059 Underlying: Common Stock · 2,059 shares Expires 2025-03-04 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F10 · derivative.exercise_date: These options vested on March 4, 2018. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 2,103 | Not disclosed Strike: $55.84 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 8 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,103 Underlying: Common Stock · 2,103 shares Expires 2024-03-05 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F9 · derivative.exercise_date: These options vested on March 5, 2017. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 4,164 | Not disclosed Strike: $30.90 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 7 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,164 Underlying: Common Stock · 4,164 shares Expires 2023-03-06 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F8 · derivative.exercise_date: These options vested on March 6, 2016. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 11,057 | Not disclosed Strike: $23.44 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 6 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,057 Underlying: Common Stock · 11,057 shares Expires 2022-02-22 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F7 · derivative.exercise_date: These options vested on February 22, 2015. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 1,337 | Not disclosed Strike: $22.66 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 5 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,337 Underlying: Common Stock · 1,337 shares Expires 2021-03-02 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F6 · derivative.exercise_date: These options vested on February 27, 2015. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantEmployee Stock Option - Right to Buy · Derivative | 9,791 | Not disclosed Strike: $22.66 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 4 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,791 Underlying: Common Stock · 9,791 shares Expires 2021-03-02 F3 · security: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. F4 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F5 · derivative.exercise_date: These options vested on March 2, 2014. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantCommon Stock | 508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · nonDerivative · entry 3 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 508 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantCommon Stock | 318 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · nonDerivative · entry 2 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 318 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantCommon Stock | 30,336 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · nonDerivative · entry 1 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,420 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. F3 · balance_after: Includes 84 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionPerformance Restricted Stock Units · Derivative | 2,076 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 27 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,076 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on March 3, 2017, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 3, 2020. F15 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on March 3, 2017, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 3, 2020. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | GrantPerformance Restricted Stock Units · Derivative | 2,076 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 26 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,076 Underlying: Ordinary Shares · 2,076 shares Expires not disclosed F15 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on March 3, 2017, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 3, 2020. F15 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on March 3, 2017, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 3, 2020. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionRestricted Stock Units · Derivative | 220 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 25 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Ordinary Shares · 220 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 220 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 219 vested on March 3, 2019, and 220 vested on March 3, 2020. F14 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 220 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 219 vested on March 3, 2019, and 220 vested on March 3, 2020. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionRestricted Stock Units · Derivative | 830 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 24 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 830 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 831 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 830 vested on March 3, 2019, and 830 vested on March 3, 2020. F13 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 831 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 830 vested on March 3, 2019, and 830 vested on March 3, 2020. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Tax withholdingOrdinary Shares | 902 | $16.29 | $14,693.58 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 14 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,336 F4 · shares: Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the performance restricted stock units (PRSUs) granted on March 3, 2017. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionOrdinary Shares | 2,076 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 13 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Tax withholdingOrdinary Shares | 75 | $16.29 | $1,221.75 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 12 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 508 F3 · shares: Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 3, 2017. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionOrdinary Shares | 220 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 11 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Tax withholdingOrdinary Shares | 364 | $16.29 | $5,929.56 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 10 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,162 F3 · shares: Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 3, 2017. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionOrdinary Shares | 830 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 9 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionRestricted Stock Units · Derivative | 384 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 23 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 770 Underlying: Ordinary Shares · 384 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 384 of the RSUs granted on March 1, 2019 vested on March 2, 2020, and 385 will vest on each of March 2, 2021 and March 2, 2022. F12 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 384 of the RSUs granted on March 1, 2019 vested on March 2, 2020, and 385 will vest on each of March 2, 2021 and March 2, 2022. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionRestricted Stock Units · Derivative | 4,129 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 22 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,258 Underlying: Ordinary Shares · 4,129 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 4,129 of the RSUs granted on March 1, 2019 vested on March 2, 2020, and 4,129 will vest on each of March 2, 2021 and March 2, 2022. F11 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 4,129 of the RSUs granted on March 1, 2019 vested on March 2, 2020, and 4,129 will vest on each of March 2, 2021 and March 2, 2022. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionRestricted Stock Units · Derivative | 167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 21 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 167 Underlying: Ordinary Shares · 167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 167 of the RSUs granted on March 2, 2018 vested on each of March 2, 2019 and March 2, 2020, and 167 will vest on March 2, 2021. F10 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 167 of the RSUs granted on March 2, 2018 vested on each of March 2, 2019 and March 2, 2020, and 167 will vest on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionRestricted Stock Units · Derivative | 1,980 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 20 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,980 Underlying: Ordinary Shares · 1,980 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 1,980 of the RSUs granted on March 2, 2018 vested on each of March 2, 2019 and March 2, 2020, and 1,980 will vest on March 2, 2021. F9 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 1,980 of the RSUs granted on March 2, 2018 vested on each of March 2, 2019 and March 2, 2020, and 1,980 will vest on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | GrantRestricted Stock Units · Derivative | 1,866 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 19 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,866 Underlying: Ordinary Shares · 1,866 shares Expires not disclosed F8 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2021. F8 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | GrantRestricted Stock Units · Derivative | 20,595 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 18 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,595 Underlying: Ordinary Shares · 20,595 shares Expires not disclosed F7 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2021. F7 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | GrantEmployee Stock Option-Right to Buy · Derivative | 669 | $0.00 Strike: $17.48 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 17 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 669 Underlying: Ordinary Shares · 669 shares Expires 2030-03-02 F6 · derivative.exercise_date: These options vest in three equal annual installments beginning on March 2, 2021 and expire on March 2, 2030. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | GrantEmployee Stock Option-Right to Buy · Derivative | 11,071 | $0.00 Strike: $17.48 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · derivative · entry 16 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,071 Underlying: Ordinary Shares · 11,071 shares Expires 2030-03-02 F5 · derivative.exercise_date: 3,691 of the options will vest on March 2, 2021 and 3,690 will vest on each of March 2, 2022 and March 2, 2023. The options expire on March 2, 2030. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Tax withholdingOrdinary Shares | 131 | $17.48 | $2,289.88 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 8 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 363 F2 · shares: Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 1, 2019. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionOrdinary Shares | 384 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 7 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Tax withholdingOrdinary Shares | 1,854 | $17.48 | $32,407.92 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 6 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,696 F2 · shares: Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 1, 2019. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionOrdinary Shares | 4,129 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 5 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Tax withholdingOrdinary Shares | 57 | $17.48 | $996.36 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 4 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 110 F1 · shares: Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2018. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionOrdinary Shares | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007019 · doc4.xml · nonDerivative · entry 3 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.